Latest News

Examining Trends From Past Respiratory Virus Seasons Can Inform New Vaccination Strategies

Expanding lung cancer screening to an age-based model significantly enhances early detection, potentially saving over 26,000 lives annually in the US.

Pharmacists remain essential to ensuring patients receive safe, effective, and accessible care amid expanding therapies.

Coffee Consumption May Reduce Depression Risk and Boost Mood, Offering Potential Benefits for Mental Health

The National Association of Boards of Pharmacy Leader Discusses the New Uniform Multistate Pharmacy Jurisprudence Examination (UMPJE), designed to standardize pharmacy law assessment while supporting multistate licensure, regulatory compliance, and patient safety.

Investigators determined a series of risk factors that can lead to complicated pneumococcal bacteremia, including older age and key comorbidities.

Pharmacists Can Incorporate the New Hypertension Guidelines Into Their Medication Therapy Management Practices

GLP-1 receptor agonists expand treatment options for diabetes, weight loss, and more, showing promise in heart failure, kidney disease, and neuroprotection.

Research funding disruptions at the National Institutes of Health (NIH) impact clinical trials, threatening treatment options for patients and highlighting the critical role of pharmacists in care continuity.

Sibeprenlimab offers a groundbreaking treatment for immunoglobulin A nephropathy, targeting APRIL to reduce kidney damage and improve patient outcomes.

Thunderstorms significantly increase asthma-related emergency visits, highlighting the need for storm-specific preparedness and management strategies for patients.

A new FDA-approved sublingual form of cyclobenzaprine HCl shows promising efficacy and tolerability in fibromyalgia.

New vaccine developments for Crimean-Congo hemorrhagic fever offer hope for prevention, highlighting pharmacists' crucial role in future vaccination efforts.

High-dose busulfan-melphalan enhances VRd therapy, improving progression-free survival in high-risk multiple myeloma patients undergoing ASCT.

Post-pandemic, invasive pneumococcal disease cases rise among youth due to declining vaccination rates, highlighting urgent public health concerns.

Tech-Check-Tech Improves Workflow and Allows Pharmacists to Focus on Clinical Responsibilities

CAR T-cell therapy shows promise for treating HER2-positive breast cancer with CNS metastases, offering a novel approach to improve patient outcomes.

The FDA approved durvalumab with FLOT chemotherapy, revolutionizing treatment for early gastric and gastroesophageal junction cancers, enhancing survival rates.